Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Center for Metabolic Regulation of Healthy Aging, Kumamoto University, Kumamoto, Japan.
Cancer Sci. 2023 Jun;114(6):2220-2229. doi: 10.1111/cas.15751. Epub 2023 Mar 5.
Tumor-associated macrophages (TAMs) are the most prominent immune cells in the breast cancer microenvironment, and the protumor functions of TAMs are thought to affect cancer progression and resistance to anticancer therapy. Numerous studies using human breast cancer samples, cell lines, and murine breast cancer models have revealed details of the mechanisms by which the protumor functions of TAMs are activated. Recent advances have highlighted the significant involvement of TAMs in the resistance of breast cancer cells to immunotherapy. Tumor-associated macrophages express a number of immunosuppressive genes, and single-cell sequence analyses of human and murine cancer samples have helped elucidate the mechanism of TAM-induced immunosuppression. As TAMs are considered suitable targets for anticancer therapies, we summarized the protumor functions of TAMs and the potential of anticancer therapies targeting TAMs, with a focus on breast cancer research.
肿瘤相关巨噬细胞(TAMs)是乳腺癌微环境中最突出的免疫细胞,TAMs 的促肿瘤功能被认为会影响癌症的进展和对抗癌治疗的耐药性。大量使用人乳腺癌样本、细胞系和小鼠乳腺癌模型的研究揭示了 TAMs 的促肿瘤功能被激活的机制细节。最近的进展强调了 TAMs 在乳腺癌细胞对免疫疗法的耐药性中的重要作用。肿瘤相关巨噬细胞表达许多免疫抑制基因,对人和鼠的癌症样本的单细胞序列分析有助于阐明 TAM 诱导免疫抑制的机制。由于 TAMs 被认为是抗癌治疗的合适靶点,我们总结了 TAMs 的促肿瘤功能和针对 TAMs 的抗癌治疗的潜力,重点关注乳腺癌研究。